Careers  |  Sign In  |  Register

Latest in Ob/Gyn

Reuters Health • The Doctor's Channel Daily Newscast

Casopitant added to ondansetron improves prevention of postop nausea

NEW YORK (Reuters Health) - Women undergoing emetogenic surgical procedures are less likely to have postoperative nausea and vomiting when treated with ondansetron plus casopitant than with ondansetron alone, researchers report in the February issue of the Archives of Surgery. Women are more prone than...

Reuters Health • The Doctor's Channel Daily Newscast

Need for ongoing progesterone in early IVF pregnancy questioned

NEW YORK (Reuters Health) – The majority of women who become pregnant after in vitro fertilization (IVF) receives progesterone throughout the first trimester, but that may not be necessary, according to a randomized controlled study. “The message of the current study is that progesterone...

Reuters Health • The Doctor's Channel Daily Newscast

Leuprolide no better than OCs for treating endometriosis pain

NEW YORK (Reuters Health) - Oral contraceptives are just as effective as a gonadotropin-releasing hormone (GnRH) agonist for relieving pelvic pain due to endometriosis, results of a small study suggest. But treatment with the GnRH agonist costs nearly 20 times more than oral contraceptives (OCs), and...